Cerus CERS
NASDAQ CERS
$2.78 -0.07 (-2.46%)
As of: Aug 20, 2026 · 3:59 PM EDT

Cerus (CERS) Cash from Investing Activities (2010 - 2026)

Cerus (CERS) posted Cash from Investing Activities of $12.9 million for Q2 2026, up 30.49% sequentially from $9.9 million in Q1 2026, and up 1281.45% YoY from $931339.7 in Q2 2025.

Cerus (CERS) Cash from Investing Activities (2010 - 2026) Analysis & Trends

Cerus has reported Cash from Investing Activities for 17 years, with the latest figure at $12.9 million in Q2 2026.

  • Quarterly Cash from Investing Activities rose 1281.45% year-over-year to $12.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $18.8 million (up 496.86% YoY) and the FY2025 annual result came in at -$6.2 million, up 24.17% from the prior year.
  • Cash from Investing Activities advanced to $12.9 million in Q2 2026 per CERS's latest filing, from $9.9 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $12.9 million in Q2 2026 and troughed at -$7.3 million in Q4 2024.
  • A 5-year average of $1.4 million and a median of -$682000.0 in 2023 frame the typical range for Cash from Investing Activities.
  • The widest YoY moves for Cash from Investing Activities: up 1851.64% in 2024, down 405.15% in 2024.
  • Over 5 years, Cash from Investing Activities stood at $7.4 million in 2022, then increased by 11.28% to $8.2 million in 2023, then sank by 188.68% to -$7.3 million in 2024, then surged by 81.09% to -$1.4 million in 2025, then soared by 1033.67% to $12.9 million in 2026.
  • According to Business Quant data, Cash from Investing Activities over the past three periods registered $12.9 million, $9.9 million, and -$1.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn -673.00 Mn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn -639.00 Mn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn -917.00 Mn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn -1.96 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn -193.20 Mn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn 329.80 Mn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn -115.00 Mn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn -22.08 Mn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn -108.50 Mn
10 Cerus 560.58 Mn 504.32 Mn 29.53 Mn 12.87 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 12.87 Mn
Jun 30, 2026 12.87 Mn
Mar 31, 2026 9.86 Mn
Mar 31, 2026 9.86 Mn
Dec 31, 2025 -1.38 Mn
Dec 31, 2025 -1.38 Mn
Sep 30, 2025 -2.51 Mn
Sep 30, 2025 -2.51 Mn
Jun 30, 2025 -1.09 Mn
Jun 30, 2025 -1.09 Mn
Mar 31, 2025 -1.19 Mn
Mar 31, 2025 -1.19 Mn
Dec 31, 2024 -7.29 Mn
Dec 31, 2024 -7.29 Mn
Sep 30, 2024 4.82 Mn
Sep 30, 2024 4.82 Mn
Jun 30, 2024 -7.11 Mn
Jun 30, 2024 -7.11 Mn
Mar 31, 2024 1.45 Mn
Mar 31, 2024 1.45 Mn